Evidence map›Paper›PMID 40807192›Full record

ArticleJournal of clinical medicine2025

Clinical Evaluation of Ripasudil for Corneal Edema: A Large-Scale Retrospective Cohort Study.

Nir Erdinest, Michael Tabi, Nadav Shemesh, Jamel Corredores, Claudia Yahalom, Yossi Eshel, Benjamin Stern, David Smadja, Zvi Gur, Itay Lavy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nir ErdinestDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0003-3327-0173
Michael TabiFaculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Nadav ShemeshDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Jamel CorredoresDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0002-2498-605X
Claudia YahalomDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0001-7747-3568
Yossi EshelDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Benjamin SternDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0001-6659-9616
David SmadjaDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0003-4168-056X
Zvi GurDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.
Itay LavyDepartment of Ophthalmology, Hadassah University Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91904, Israel.ORCID 0000-0001-5213-3196

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

corneal edemaendothelial dysfunctionRho-associated protein kinase inhibitorRipasudiltopical therapy

Identifiers

PMID40807192
PMCPMC12347265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.